Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 55Active not recruiting 23Terminated 21Recruiting 15Unknown 9Not yet recruiting 3Withdrawn 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 4Thoracic 3Genitourinary 3Gastrointestinal 3Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Post-Acute COVID-19 Syndrome 1Lung Neoplasms 1

Interventions

Carboplatin 63Cisplatin 40Pemetrexed 38Drug Therapy 37osimertinib 22anlotinib 22Etoposide 20tislelizumab 17Radiotherapy 17Paclitaxel 17Surgical Procedures, Operative 16pembrolizumab 15toripalimab 14130-nm albumin-bound paclitaxel 14aflutinib 13Docetaxel 13Bevacizumab 12sintilimab 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Injections 9durvalumab 8cemiplimab 8Radiosurgery 8Platinum 8PM 01183 8Immunotherapy 8atezolizumab 7Platinum Compounds 7Blood Specimen Collection 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Ipilimumab × Thoracic × Clear all
NCT07355205 2026-05-22

FLINN

Washington University School of Medicine

Phase 2 Not yet recruiting
26 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07603856 2026-05-22

REVIVE

University of Chicago

Phase 2 Not yet recruiting
39 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05597800 2022-10-28

LUNGVIR

Universita di Verona

Phase 2 Not yet recruiting
105 enrolled
Thoracic

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡